Skip to main content
Displaying 1 - 12 of 15
Display:
12
24
48
Liver Tumours
Welcome, introductions, and overview of current HCC treatment
Webcasts
View
Liver Tumours
Emerging data and remaining knowledge gaps in advanced HCC
Webcasts
View
Liver Tumours
Treatment landscape and unmet needs in early and intermediate HCC
Webcasts
View
Liver Tumours
Live virtual panel discussion and audience Q&A
Webcasts
View
Liver Tumours
Closing remarks
Webcasts
View
Metabolism, Alcohol & Toxicity
The NASH care pathway: Drivers and emerging trends
Webcasts
View
Metabolism, Alcohol & Toxicity
How to optimise NASH patient care? – Collaboration with different specialities
Webcasts
View
Metabolism, Alcohol & Toxicity
How do non-invasive techniques improve patient identification and risk stratification?
Webcasts
View
Metabolism, Alcohol & Toxicity
Future improvements needed for care pathways for patients with NASH – Q&A
Webcasts
View
General Hepatology
Chair’s welcome
Webcasts
View
General Hepatology
New insights into the role of FXR agonism in PBC
Webcasts
View
General Hepatology
Obethicolic Acid in the real world: what have we learned so far? Experience from Spain and Portugal
Webcasts
View
Pagination
Current page
1
Page
2
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy